CTAB, Triton X-100 and freezing–thawing treatments of Candida guilliermondii: Effects on permeability and accessibility of the glucose-6-phosphate dehydrogenase, xylose reductase and xylitol dehydrogenase enzymes
Cells of Candida guilliermondii (ATCC 201935) were permeabilised with surfactant treatment (CTAB or Triton X-100) or a freezing–thawing procedure. Treatments were monitored by in situ activities of the key enzymes involved in xylose metabolism, that is, glucose-6-phosphate dehydrogenase (G6PD), xylo...
Gespeichert in:
Veröffentlicht in: | New biotechnology 2012-01, Vol.29 (2), p.192-198 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Cells of
Candida guilliermondii (ATCC 201935) were permeabilised with surfactant treatment (CTAB or Triton X-100) or a freezing–thawing procedure. Treatments were monitored by
in situ activities of the key enzymes involved in xylose metabolism, that is, glucose-6-phosphate dehydrogenase (G6PD), xylose reductase (XR) and xylitol dehydrogenase (XD). The permeabilising ability of the surfactants was dependent on its concentration and incubation time. The optimum operation conditions for the permeabilisation of
C. guilliermondii with surfactants were 0.41
mM (CTAB) or 2.78
mM (Triton X-100), 30
°C, and pH 7 at 200
rpm for 50
min. The maximum permeabilisation measured in terms of the
in situ G6PD activity observed was, in order, as follows: CTAB (122.4
±
15.7
U/g
cells) > freezing–thawing (54.3
±
1.9
U/g
cells)
>
Triton X-100 (23.5
±
0.0
U/g
cells). These results suggest that CTAB surfactant is more effective in the permeabilisation of
C. guilliermondii cells in comparison to the freezing–thawing and Triton X-100 treatments. Nevertheless, freezing–thawing was the only treatment that allowed measurable
in situ XR activity. Therefore, freezing–thawing permeabilised yeast cells could be used as a source of xylose reductase for analytical purposes or for use in biotransformation process such as xylitol preparation from xylose. The level of
in situ xylose reductase was found to be 13.2
±
0.1
U/g
cells. |
---|---|
ISSN: | 1871-6784 1876-4347 |
DOI: | 10.1016/j.nbt.2011.05.011 |